Skip to main content
Category

Uncategorized

BioPharm

Media Alert: Leading Local Biotech Firms to Host Aspiring Young Scientists Next Week | Fort Mill Times – Fort Mill, SC

By Uncategorized

BioPharm

Montgomery County’s top biotechnology firms will open their doors and their state-of-the-art laboratories next week to local middle school students interested in the life sciences. In a partnership with MdBio Foundation, Inc., and Montgomery College, preeminent local scientists and executives from MedImmune, Qiagen and Emergent BioSolutions will share their expertise and career stories with students from the Young Science Explorers Program (YSEP), a weeklong science workshop for rising seventh and eighth grade students.

Dressed in lab coats and safety glasses, students will get once in a lifetime exposure to local companies and scientists on the leading edge of medical breakthroughs. Topics will range from microbiology and vaccine research to lab safety and potential career paths for science students.

Read More
July 5, 2013
Love0
bhi-logo

BHI Internship Program: Positions Available

By Uncategorized

bhi-logo

BioHealth Innovation, Inc., (BHI) a non-profit organization which strives to facilitate the development of commercially viable health IT products and companies by connecting market relevant research assets to appropriate funding, management and markets, is seeking interns as part of the BHI Internship Program.

POSITION DESCRIPTION – BHI Intern

BioHealth Innovation, Inc. (BHI), a regional private-public partnership focusing on commercializing market-relevant biohealth innovations and increasing access to early-stage funding in Central Maryland, is seeking highly motivated and dynamic individuals to fill internship positions at the Rockville, MD headquarters.  The BHI Internship Program offers essential experience for IT, Business, and Biohealth students in the region.  By offering a variety of projects and responsibilities to students, BHI aims to prepare interns for professional careers in the business, life sciences, healthcare and IT industries.

Read More
June 27, 2013
Love0

NIAID SBIR Phase II Clinical Trial Implementation Cooperative Agreement (U44)

By Uncategorized

…

Funding Opportunity Number: PAR-13-250
Opportunity Category: Discretionary
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
CFDA Number: 93.855
93.856
Eligible Applicants Small businesses
Agency Name: HHS-NIH11
Closing Date: May 13, 2016
Award Ceiling:
Expected Number of Awards:
Creation Date: Jun 24, 2013
Funding Opportunity Description: This Funding Opportunity Announcement (FOA) invites Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to implement investigator-initiated clinical trials related to the research mission of the NIAID. This program will utilize the cooperative agreement mechanism (U44) to enable support for hypothesis-driven, milestone-driven clinical trials. Although clinical trials not considered high-risk may be proposed, this program encourages high-risk clinical studies. High-risk does not imply human subject or patient risk, but rather defines a study that contains one or more of the following unique features: involves non-routine interventions, administration of an unlicensed product, or administration of a licensed product for an unapproved indication. Mechanistic studies are also encouraged and can be proposed under this program. However, not more than one clinical trial should be proposed within each grant application. The NIAID has a robust infrastructure for conducting clinical studies that includes independently managed resources provided through grants and contracts, as well as resources that are integrated within existing NIAID-supported clinical trial networks. Proposed clinical trials may use NIAIDs independent infrastructure for clinical studies, however, support will not be provided for studies that propose to use dedicated resources that are part of a NIAID-supported clinical trial network. A Commercialization Plan must be included that details plans for promoting further commercialization of the intervention/product/technology to be derived from or associated with the proposed clinical trial, including plans for promoting and establishing partnerships between the SBIR Phase II awardee and third-party investors and/or strategic partners.

Read more http://www.grants.gov/search/search.do?mode=VIEW&oppId=236728

Read More
June 27, 2013
Love0

Revolutionary Genome Sequencing Technologies The $1000 Genome (R01)

By Uncategorized

…

Funding Opportunity Number: RFA-HG-13-005
Opportunity Category: Discretionary
Funding Instrument Type: Grant
Category of Funding Activity: Health
CFDA Number: 93.172
Eligible Applicants State governments
County governments
City or township governments
Special district governments
Independent school districts
Public and State controlled institutions of higher education
Native American tribal governments (Federally recognized)
Public housing authorities/Indian housing authorities
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
For profit organizations other than small businesses
Small businesses
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Agency Name: HHS-NIH11
Closing Date: Oct 17, 2013
Award Ceiling: $1,000,000
Expected Number of Awards:
Creation Date: Jun 26, 2013
Funding Opportunity Description: The National Human Genome Research Institute (NHGRI) solicits R01 grant applications to develop novel technologies that will enable extremely low-cost, high quality DNA sequencing. The goal of this initiative is to reduce the cost of sequencing a mammalian-sized genome to approximately $1000. Applicants may propose to develop full-scale sequencing systems or to investigate challenges underlying key system components. Exploration of methods other than those currently being pursued as potential $1,000 genome technologies is encouraged. High-risk/high-payoff applications are appropriate to achieve the goals of this FOA.

Read more http://www.grants.gov/search/search.do?mode=VIEW&oppId=236793

Read More
June 27, 2013
Love0

Revolutionary Genome Sequencing Technologies The $1000 Genome (SBIR [R43/R44])

By Uncategorized

…

Funding Opportunity Number: RFA-HG-13-007
Opportunity Category: Discretionary
Funding Instrument Type: Grant
Category of Funding Activity: Health
CFDA Number: 93.172
Eligible Applicants Small businesses
Agency Name: HHS-NIH11
Closing Date: Oct 17, 2013
Award Ceiling:
Expected Number of Awards:
Creation Date: Jun 26, 2013
Funding Opportunity Description: The National Human Genome Research Institute (NHGRI) solicits SBIR (R43/R44) grant applications to develop novel technologies that will enable extremely low-cost, high quality DNA sequencing. The goal of this initiative is to reduce the cost of sequencing a mammalian-sized genome to approximately $1000. Applicants may propose to develop full-scale sequencing systems or to investigate challenges underlying key system components. Exploration of methods other than those currently being pursued as potential $1,000 genome technologies is encouraged. High-risk/high-payoff applications are appropriate to achieve the goals of this FOA.

Read more http://www.grants.gov/search/search.do?mode=VIEW&oppId=236794

Read More
June 27, 2013
Love0
Barbara Mikulski

Mikulski to Kick Off USM/JHU Symposium on Future of Maryland Research and Innovation Education

By Uncategorized

Senator to discuss findings of National Academy of Sciences report she requested on maintaining excellence at American research universities

Barbara Mikulski

At 8:00 a.m. on Thursday, June 20, 2013, U.S. Senator Barbara A. Mikulski (D-Md.) will kick off a symposium hosted by the University System of Maryland (USM) and Johns Hopkins University (JHU) to discuss the future of Maryland research and innovation education. Senator Mikulski will discuss the findings of a report by the National Academy of Sciences, Research Universities and the Future of America. Senator Mikulski requested the report to ensure the continued success of America’s research and doctoral education institutions.

The National Research Council has asked major research universities to host regional symposia as a means of giving the report greater national visibility and providing a roadmap for how state and federal governments along with the private sector and research universities can work together to maintain excellence in research, preparing students today for jobs tomorrow.

Read More
June 20, 2013
Love0

Research to Characterize and Reduce Stigma to Improve Health (R01) – Sep 07, 2016

By Uncategorized

…

Funding Opportunity Number: PA-13-248
Opportunity Category: Discretionary
Funding Instrument Type: Grant
Category of Funding Activity: Education
Health
CFDA Number: 93.172
93.173
93.242
93.393
93.394
93.395
93.396
93.397
93.398
93.399
93.853
93.866
Eligible Applicants State governments
County governments
City or township governments
Special district governments
Independent school districts
Public and State controlled institutions of higher education
Native American tribal governments (Federally recognized)
Public housing authorities/Indian housing authorities
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
For profit organizations other than small businesses
Small businesses
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Agency Name: HHS-NIH11
Closing Date: Sep 07, 2016
Award Ceiling:
Expected Number of Awards:
Creation Date: Jun 14, 2013
Funding Opportunity Description: This Funding Opportunity Announcement (FOA) encourages research grant applications to characterize the role of stigma in health, life course development, and aging, both in the U.S. and globally, and to test interventions to prevent or reduce the impact of stigma at the individual, community, health care system, and policy levels. The goal of this FOA is to promote research addressing the health-related aspects of stigma, including the etiology and perpetuation of stigma; its impact on physical and mental health, well-being, life course development, and aging; its influence on health behaviors and on use, access to, and quality of received healthcare services; its contribution to health disparities affecting vulnerable demographic groups; and intervention strategies to reduce health-related stigma and/or the negative health and life course developmental impacts of stigma.

Read more http://www.grants.gov/search/search.do?mode=VIEW&oppId=236394

Read More
June 18, 2013
Love0
mimetas-wins

MIMETAS wins LifeSciences@Work award

By Uncategorized

mimetas-winsMaarssen, the Netherlands, 14 June 2013 – MIMETAS was awarded the prestigious LifeSciences@Work award during yesterdays’ Dutch Life Sciences SME Event. 75 recently established Life Science companies were invited to compete through an on-line video pitch contest. The video pitches were analyzed by a professional jury, consisting of primarily investors and life science professionals.

Read Full Article

June 14, 2013
Love0
crp-logo-250

NIH SBIR Phase I Summer Assistance Program

By Uncategorized

crp-logo-250

BioHealth Innovation is working to assist relevant SBIR projects through its Commercial Relevance Program for the August 5th, 2013 NIH SBIR Deadline.

If your company is planning a submission for the August 5 deadline, BioHealth Innovation can assist with your submission. Through the BHI Commercial Relevance Program for SBIR/STTR projects select companies submit their federal funding concepts and receive pre-proposal feedback to help strengthen your application. Further support from BHI’s network of professional consultants and service providers is available to assist in improving your application. If you’re are planning a submission for the August 5 deadline contact Ethan Byler for details on possible support from BHI.

NIH SBIR Phase I Program

  1. Companies to complete brief application describing the proposed SBIR project apply by June 18th
  2. All companies notified of SBIR assistance by June 26th
  3. Guidance, writing strategy, direction, and review sessions to be schedule to enable you through grant submission
  4. Feedback and redlined comments on written drafts and proposals materials as well as final submission assistance
June 4, 2013
Love0
Biohealth ResourceGuideFinal Online Page 001

BHI and EAGB release the First Edition of the Central Maryland BioHealth Entrepreneur’s Resource and Finance Guide

By Uncategorized

Biohealth ResourceGuideFinal Online Page 001ROCKVILLE, MARYLAND, June 4, 2013 – BioHealth Innovation, Inc. (BHI), a regional private-public partnership focusing on commercializing market-relevant biohealth innovations and increasing access to early-stage funding in Central Maryland, is proud to announce the publication of the Central Maryland BioHealth Entrepreneur’s Resource and Finance Guide 2013. The Guide was developed by BHI, the Economic Alliance of Greater Baltimore and the Montgomery County Department of Economic Development, in collaboration with the Baltimore Business Journal.

The Guide serves as a compendium of resources to biohealth innovators and entrepreneurs working to start and grow new companies and technologies in the region. This essential entrepreneurial resource includes a compilation of information on financial resources, university facilities and programs, economic development programs, and existing federal laboratory facilities and programs, as well as how to work with these assets. The Guide is one of the many projects BHI is developing to successfully transform the regional environment for biohealth startups through harnessing Central Maryland’s biohealth assets and establishing an entrepreneurial ecosystem.

The Guide has been distributed through the Baltimore and Washington business journal subscribers, and is being distributed to all regional partners. For your copy of the guide please download here or contact BioHealth Innovation for details on how to receive a hard copy.

Download the Central Maryland BioHealth Entrepreneur’s Resource and Finance Guide

 

June 4, 2013
Love0

Search

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.